Evotec SE

EVT.SW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EVT.SW stands at 4.78B. In comparison, SDZ.SW has a market cap of 16.38B. Regarding current trading prices, EVT.SW is priced at $26.96, while SDZ.SW trades at $38.03.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EVT.SW currently has a P/E ratio of -25.92, whereas SDZ.SW's P/E ratio is -1901.50. In terms of profitability, EVT.SW's ROE is -0.19%, compared to SDZ.SW's ROE of +0.01%. Regarding short-term risk, EVT.SW is less volatile compared to SDZ.SW. This indicates potentially lower risk in terms of short-term price fluctuations for EVT.SW.

EVT.SW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EVT.SW stands at 4.78B. In comparison, SFZN.SW has a market cap of 4.40B. Regarding current trading prices, EVT.SW is priced at $26.96, while SFZN.SW trades at $97.60.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EVT.SW currently has a P/E ratio of -25.92, whereas SFZN.SW's P/E ratio is 26.45. In terms of profitability, EVT.SW's ROE is -0.19%, compared to SFZN.SW's ROE of +0.14%. Regarding short-term risk, EVT.SW is less volatile compared to SFZN.SW. This indicates potentially lower risk in terms of short-term price fluctuations for EVT.SW.

EVT.SW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EVT.SW stands at 4.78B. In comparison, PPGN.SW has a market cap of 664.88M. Regarding current trading prices, EVT.SW is priced at $26.96, while PPGN.SW trades at $20.15.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EVT.SW currently has a P/E ratio of -25.92, whereas PPGN.SW's P/E ratio is -36.64. In terms of profitability, EVT.SW's ROE is -0.19%, compared to PPGN.SW's ROE of -0.05%. Regarding short-term risk, EVT.SW is less volatile compared to PPGN.SW. This indicates potentially lower risk in terms of short-term price fluctuations for EVT.SW.

EVT.SW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EVT.SW stands at 4.78B. In comparison, VIFN.SW comparison data is unavailable. Regarding current trading prices, EVT.SW is priced at $26.96, while VIFN.SW trades at $166.15.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EVT.SW currently has a P/E ratio of -25.92, whereas VIFN.SW's P/E ratio is N/A. In terms of profitability, EVT.SW's ROE is -0.19%, compared to VIFN.SW's ROE of +0.08%. Regarding short-term risk, EVT.SW is less volatile compared to VIFN.SW. This indicates potentially lower risk in terms of short-term price fluctuations for EVT.SW.

EVT.SW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EVT.SW stands at 4.78B. In comparison, MER.SW comparison data is unavailable. Regarding current trading prices, EVT.SW is priced at $26.96, while MER.SW trades at $102.20.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EVT.SW currently has a P/E ratio of -25.92, whereas MER.SW's P/E ratio is 14.20. In terms of profitability, EVT.SW's ROE is -0.19%, compared to MER.SW's ROE of +0.14%. Regarding short-term risk, EVT.SW and MER.SW have similar daily volatility (0.00).